One-Stop Prolastin Direct® Patient Services

Prolastin Direct Process Flow

Prolastin Direct® Patient Services is a unique medication delivery and health management service and more, which makes managing Alpha-1 easier.

Prolastin Direct Process Flow

Prolastin Direct® Patient Services enables you to directly receive PROLASTIN-C when and where you need it in the United States. Prolastin Direct® Patient Services reimbursement experts have a 99% success rate in gaining insurance authorization for therapy.1

Call Prolastin Direct® at 800-305-7881 with questions about insurance coverage, delivery of PROLASTIN-C and nursing services. Learn more about other options for help with insurance and co-pays.

How Prolastin Direct® works:

When your doctor prescribes PROLASTIN-C, you will automatically be enrolled in Prolastin Direct® Patient Services.

Prolastin Direct® Patient Services helps you get started on therapy and makes sure you get your therapy on time where you need it. Prolastin Direct® staff:

  • Coordinates authorization for therapy between your doctor and your insurance company
  • Calls you to see where and when you want to receive your infusions of PROLASTIN-C*
  • Makes arrangements for all nursing services and supplies
  • Arranges delivery of PROLASTIN-C to your home, your doctor's office, the infusion center at the local hospital, or any other location you choose
  • Makes sure your Prolastin Direct® case manager arranges for nursing services and delivery of PROLASTIN-C to wherever you're staying if you happen to be traveling
  • Connects you with an AlphaNet Coordinator, to start you in the optional health management program

Coordinators from AlphaNet, who are Alpha patients themselves, will call you at least once a month, with your permission, to:

  • Offer education and support with information about the disease, therapy, life style changes and other health management services
  • Connect you to support groups and others with Alpha-1
  • Alert you about news & events in the Alpha-1 community

* The exact date, delivery, location, and amount of the first and subsequent shipments are dependent upon your doctor’s orders insurance authorization.

Patients participating with Prolastin Direct® patient services do better than patients just on therapy without health management support

A clinical study of Alpha-1 showed that patients who received augmentation therapy, such as PROLASTIN, plus the health management services of Prolastin Direct® Patient Services, experienced 10% fewer exacerbations compared with patients who received augmentation therapy alone.1

Excerbation Reduction Graph

If you are considering PROLASTIN-C for augmentation therapy, call Prolastin Direct® Patient Services at 800-305-7881 to enroll.

next: Insurance & Payment Support >

Important Safety Information
Prolastin-C, Alpha1-Proteinase Inhibitor (Human) is for adults who have emphysema caused by inherited alpha1-antitrypsin deficiency. The effect of therapy with any alpha1-proteinase inhibitor (alpha1-PI) on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Prolastin-C may contain trace amounts of IgA. IgA deficient patients with antibodies against IgA should not receive Prolastin-C due to the risk of hypersensitivity.

The most common side effects during clinical trials with Prolastin-C were chills, a general feeling of being unwell, headache, rash, hot flush, and itching.

Prolastin-C is made from human plasma. Products made from human plasma may carry a risk of transmitting infectious agents, e.g., viruses, and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

Please see accompanying Prolastin-C Full Prescribing Information for complete prescribing details.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

References
  1. Data on file. Centric Health Resources.